Results 111 to 120 of about 162,637 (248)

Central Retinal Vein Occlusion in the Absence of Conventional Risk Factors Associated With Breast Carcinoma: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 9, September 2026.
Unusual association of central retinal vein occlusion and breast carcinoma. ABSTRACT Central retinal vein occlusion in 41‐year‐old female patients without conventional risk factors should raise concern for systemic evaluation for underlying malignancy and treatment‐related hypercoagulability.
Hamna Danyal Barry   +5 more
wiley   +1 more source

Retinal ganglion cell function after repeated intravitreal injections of ranibizumab in patients with age-related macular degeneration

open access: yesClinical Ophthalmology, 2012
Tomoharu Nishimura, Shigeki Machida, Tomomi Harada, Daijiro KurosakaDepartment of Ophthalmology, Iwate Medical University School of Medicine, Morioka, Iwate, JapanBackground: The purpose of this study was to evaluate the safety of intravitreal ...
Nishimura T   +3 more
doaj  

Effect of intravitreal injections due to neovascular age-related macular degeneration on retinal nerve fiber layer thickness and minimum rim width: a cross sectional study

open access: yesBMC Ophthalmology
Purpose The present study tested the hypothesis that repeated anti-VEGF injections are associated with reduced retinal nerve fiber layer (RNFL) and minimum rim width (MRW) of the optic nerve head. Patients and methods Sixty-six patients with a history of
Agnes Boltz   +4 more
doaj   +1 more source

FOXO6 inhibits SMURF2‐mediated ubiquitination and degradation of NR4A1 to promote retinal pigment epithelial cell ferroptosis in diabetic retinopathy

open access: yesJournal of Cell Communication and Signaling, Volume 20, Issue 3, September 2026.
FOXO6 suppresses the transcriptional expression of SMURF2, thereby limiting the ubiquitination and degradation of NR4A1. Stabilized NR4A1 promotes ferroptosis in RPE cells, contributing to the progression of diabetic retinopathy. Abstract Diabetic retinopathy (DR) is the main cause of vision loss, with retinal pigment epithelial (RPE) cell dysfunction ...
Qiao Chen   +4 more
wiley   +1 more source

Patients' tolerance of bimanual lid retraction versus a metal speculum for intravitreal injections

open access: yesClinical Ophthalmology, 2016
Khadijah Alattas Department of Ophthalmology, College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia Objective: To compare patients’ acceptance of and correlate their pain level for bimanual versus metal speculum fixation in ...
Alattas K
doaj  

Safety of bilateral intravitreal injections delivered in a teaching institution

open access: yes, 2014
Intravitreal injection is one of the most common in-office procedures performed in ophthalmic practices. In teaching institutions such as the Veterans Affairs (VA) Hospitals, patient care is delivered by physicians-in-training, while mastering ...
Khandji, Joyce   +3 more
core   +1 more source

Construction and Validation of a Long‐Term Visual Prognosis Prediction Model for Proliferative Diabetic Retinopathy After Vitrectomy Based on Machine Learning

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 5, September 2026.
This study developed and validated a machine learning‐based prognostic model for predicting long‐term visual outcomes after pars plana vitrectomy (PPV) in patients with proliferative diabetic retinopathy. ABSTRACT Introduction This study aims to develop a machine‐learning‐based risk prediction model for a long‐term visual prognosis in patients with ...
Xiaolu Wang   +7 more
wiley   +1 more source

Refractive changes after intravitreal ranibizumab injections for diabetic macular oedema

open access: yes, 2018
Purpose: The purpose of this study was to evaluate refractive changes after intravitreal ranibizumab injections for the treatment of diabetic macular oedema.
Dimitriou, E.   +5 more
core   +1 more source

Endophthalmitis Associated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections

open access: yes, 2014
The use of anti-vascular endothelial growth factor (VEGF) agents has led to a dramatic increase in the number of intravitreal injections. Endophthalmitis remains a rare but potentially vision-threatening complication of intravitreal injections.
Flynn Jr, Harry, Schwartz, Stephen
core   +1 more source

Home - About - Disclaimer - Privacy